Aquestive Therapeutics Sees FY24 Revenue $57M-$60M Vs $49.792M Est.
Portfolio Pulse from Benzinga Newsdesk
Aquestive Therapeutics has projected its FY24 revenue to be between $57 million and $60 million, surpassing the estimated $49.792 million.
August 06, 2024 | 9:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aquestive Therapeutics has projected its FY24 revenue to be between $57 million and $60 million, surpassing the estimated $49.792 million.
The revenue projection significantly exceeds the market estimate, which is likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100